We only have this paper's title and publication details.
Read it at the sourceImmunohistochemistry staining reveals PD-L1 expression in a multiomics cohort, suggesting tailored therapies may improve outcomes for breast cancer patients.
Fig. S5 PD-L1 (22C3) Immunohistochemistry staining in the multiomics cohort.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: